Section 6 of 6
References
82 sources
- Arora et al. (2023) (opens in a new tab)
- Banerji et al. (2018) (opens in a new tab)
- Beard et al. (2022) (opens in a new tab)
- Betschel et al. (2026) (opens in a new tab)
- Broderick et al. (2025) (opens in a new tab)
- Busse et al. (2021) (opens in a new tab)
- Busse et al. (2026) (opens in a new tab)
- Castaldo et al. (2021) (opens in a new tab)
- Cohn et al. (2025) (opens in a new tab)
- Cohn et al. (2026) (opens in a new tab)
- Craig et al. (2023) (opens in a new tab)
- Craig et al. (2026) (opens in a new tab)
- CSL (2023) (opens in a new tab)
- CSL Behring (2022) (opens in a new tab)
- CSL Behring (2026) (opens in a new tab)
- EU Clinical Trials Register 2013-000916-10 (opens in a new tab)
- Farkas and Balla (2024) (opens in a new tab)
- FDA (opens in a new tab)
- FDA (opens in a new tab)
- FDA (2018) (opens in a new tab)
- FDA (2020) (opens in a new tab)
- FDA (2025) (opens in a new tab)
- FDA (2025) (opens in a new tab)
- FDA (2025) (opens in a new tab)
- Feld et al. (2026) (opens in a new tab)
- Guan et al. (2024) (opens in a new tab)
- Henao et al. (2016) (opens in a new tab)
- ICER (2021) (opens in a new tab)
- Intellia Therapeutics (opens in a new tab)
- Intellia Therapeutics (opens in a new tab)
- Intellia Therapeutics (opens in a new tab)
- Intellia Therapeutics (2022) (opens in a new tab)
- Intellia Therapeutics (2023) (opens in a new tab)
- Intellia Therapeutics (2024) (opens in a new tab)
- Intellia Therapeutics (2025) (opens in a new tab)
- Intellia Therapeutics (2026) (opens in a new tab)
- Intellia Therapeutics (2026) (opens in a new tab)
- Intellia Therapeutics (2026) (opens in a new tab)
- Intellia Therapeutics (2026) (opens in a new tab)
- Intellia Therapeutics AAAAI poster (2025) (opens in a new tab)
- Intellia Therapeutics AAAAI poster (2026) (opens in a new tab)
- Intellia Therapeutics AAAAI poster (2026) (opens in a new tab)
- Intellia Therapeutics AAAAI poster (2026) (opens in a new tab)
- Intellia Therapeutics AAAAI presentation (2021) (opens in a new tab)
- Intellia Therapeutics ACAAI poster (2025) (opens in a new tab)
- Intellia Therapeutics ACAAI presentation (2025) (opens in a new tab)
- Intellia Therapeutics corporate overview (2026) (opens in a new tab)
- Intellia Therapeutics EAACI presentation (2025) (opens in a new tab)
- Intellia Therapeutics EAACI presentation (2026) (opens in a new tab)
- Intellia Therapeutics Form 10-K (2026) (opens in a new tab)
- Intellia Therapeutics Form 10-Q (2026) (opens in a new tab)
- Intellia Therapeutics investor presentation (2024) (opens in a new tab)
- Intellia Therapeutics presentation (2026) (opens in a new tab)
- Ionis Pharmaceuticals protocol and statistical analysis plan (2023) (opens in a new tab)
- Jalal et al. (2025) (opens in a new tab)
- Kutrieb et al. (2026) (opens in a new tab)
- Longhurst et al. (2017) (opens in a new tab)
- Longhurst et al. (2023) (opens in a new tab)
- Longhurst et al. (2024) (opens in a new tab)
- Lumry et al. (2021) (opens in a new tab)
- Luong et al. (2026) (opens in a new tab)
- Maurer et al. (2022) (opens in a new tab)
- MedlinePlus (opens in a new tab)
- Olson et al. (2026) (opens in a new tab)
- Pardi and Ivics (2024) (opens in a new tab)
- Princic et al. (2025) (opens in a new tab)
- Riedl et al. (2024a) (opens in a new tab)
- Riedl et al. (2024b) (opens in a new tab)
- Sandberg et al. (2024) (opens in a new tab)
- Somatic Cell Gene Editing Consortium NCT05120830 (opens in a new tab)
- Somatic Cell Gene Editing Consortium NCT06634420 (opens in a new tab)
- Uminski et al. (2025) (opens in a new tab)
- US Hereditary Angioedema Association (opens in a new tab)
- Vanya et al. (2023) (opens in a new tab)
- Vázquez et al. (2026) (opens in a new tab)
- Villa et al. (2026) (opens in a new tab)
- Walsh et al. (2022) (opens in a new tab)
- Walsh et al. (2025) (opens in a new tab)
- Watt et al. (2026) (opens in a new tab)
- Weller et al. (2016) (opens in a new tab)
- Zuraw et al. (2021) (opens in a new tab)
- Zuraw et al. (2025) (opens in a new tab)